RxDoctor Payments DataLook up a doctor →

Polina Samoylova, NP

Family · Tucson, AZNPI 1295211159

Payments from drug & device makers

$17,726in general payments, 2019–2025

Across 1,092 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • UCB, Inc.$2K
  • Novartis$1K
  • Biogen$1K
  • AstraZeneca$919
  • Teva Pharmaceuticals USA, Inc.$887
  • plus $10K from 54 others

What the payments were for

  • Speaking & faculty fees$520%
  • Food & beverage$17,50099%
  • Education$1741%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)158$2,156
UCB, Inc.114$1,656
Novartis92$1,333
Biogen91$1,226
AstraZeneca28$919
Teva Pharmaceuticals USA, Inc.62$887
Lilly USA, LLC60$876
Banner Life Sciences, LLC46$669
Pfizer46$597
Lundbeck LLC46$573
Amgen(2 entities)30$527
Sanofi25$503
Argenx US, Inc.21$500
Eisai Inc.24$398
Otsuka America Pharmaceutical, Inc.14$371
Neurocrine Biosciences, Inc.13$359
Genentech USA, Inc.11$287
Bristol Myers Squibb20$276
Amneal Pharmaceuticals LLC20$256
CSL Behring10$237
TG Therapeutics, Inc.10$201
Sunovion Pharmaceuticals Inc.18$191
Johnson & Johnson(2 entities)5$184
Scilex Pharmaceuticals Inc.8$170
Grifols USA, LLC4$158
Biohaven Pharmaceuticals, Inc.13$141
Mallinckrodt Hospital Products Inc.6$128
Merz Pharmaceuticals, LLC6$128
Acadia Pharmaceuticals Inc5$127
Neurelis, Inc.7$126
Jazz Pharmaceuticals Inc.4$122
Axsome Therapeutics, Inc.5$103
EMD Serono, Inc.4$95
Kyowa Kirin, Inc.5$93
Cycle Pharmaceuticals Inc5$91
Vanda Pharmaceuticals Inc.4$78
Catalyst Pharmaceuticals, Inc.3$75
Corium, LLC3$69
Avion Pharmaceuticals3$69
SK Life Science, Inc.4$68
Biohaven Pharmaceutical Holding Company Ltd.4$66
Tanabe Pharma America, Inc.3$65
Sumitomo Pharma America, Inc.4$53
Acorda Therapeutics, Inc3$52
Harmony Biosciences LLC2$50
E.r. Squibb & Sons, L.L.C.2$42
GE HealthCare2$41
Boston Scientific2$40
Medtronic2$37
Noctrix Health, Inc.1$36
Supernus Pharmaceuticals, Inc.2$35
Octapharma USA, Inc.1$29
Averitas Pharma Inc.2$27
Takeda Pharmaceuticals U.S.A., Inc.1$26
ANI Pharmaceuticals, Inc.2$25
Impel Pharmaceuticals LLC1$25
Abbott1$15
Arbor Pharmaceuticals, Inc.1$12
Impel Pharmaceuticals Inc.1$12
Otto Bock Healthcare LP1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,726 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$148,598
Medicare patients
530
Services billed
1,221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →